Hudson Institute is a leading Australian medical research institute recognised internationally for discovery science and translational research. We are research leaders in four areas of medical need 1. Reproductive health and pregnancy – addressing the challenges of infertility and complications during pregnancy, and progressing women’s health. 2. Infant and child health – protecting vulnerable newborns from complications during birth, in the critical early weeks of life and exploring better treatments for childhood diseases. 3. Inflammation – exploring how our body responds to infection and tissue damage with inflammation, and using this knowledge to fight infectious diseases, cancer and autoimmune diseases. 4. Cancer – investigating the molecular and cellular mechanisms that lead to the development of cancer and how these insights may be used to better diagnose, detect and treat malignancies. Our 475 scientists study human health and disease at a molecular and cellular level to discover how biological systems work and how disease and disability can be prevented or treated. Our close ties with clinicians and industry give us the ability to translate our discoveries into new preventative approaches, therapies and devices for patients. We are a founding member of the Monash Health Translation Precinct with partners Monash Health (Victoria’s largest healthcare network) and Monash University (Australia’s largest university). Our integrated research teams include clinicians, nurses and clinical trial coordinators who both inform research programs based on patient need and advance these discoveries back to the clinic. Working alongside clinicians in Melbourne hospitals for more than 50 years, Hudson Institute scientists pioneered IVF and stem cell discoveries and are now leading developments in paediatric cancer and the human microbiome. Our worldwide scientific and medical collaborations provide a foundation for transformative healthcare programs across the globe.